The first-line drugs for hypertension treatment are ACE inhibitors (ACEi, -prils) and Angiotensin II Receptor Blockers (ARBs, -sartans), which are clearly established to increase ACE2 levels [19] and could contribute to COVID-19 severity. This evidence concerns the gene ACE and COVID-19.